“[Clinical and Economic Evaluation of the Introduction of the Combinazion Trametinib + Dabrafenib in the Management of Advanced Melanoma in the Italian Market]”. Farmeconomia. Health Economics and Therapeutic Pathways 17, no. 3S (December 21, 2016): 1–32. Accessed December 28, 2025. https://journals.seedstm.com/index.php/FE/article/view/1279.